2020
Постійне посилання на фонд
Переглянути
Перегляд 2020 за Ключові слова "alimentary obesity"
Зараз показуємо 1 - 2 з 2
Результатів на сторінці
Налаштування сортування
Документ Application of pioglitazone in the comprehensive treatment of psoriatic patients with concomitant alimentary obesity(Полтавський державний медичний університет, 2020) Yemchenko, Ya. O.; Ishcheikin, K. Ye.; Kaidashev, I. P.; Ємченко, Яна Олександрівна; Іщейкін, Костянтин Євгенович; Кайдашев, Ігор ПетровичPsoriasis is one of the most common chronic recurrent systemic autoimmune multifactorial diseases, in which the skin, joints, internal organs and systems of the body are involved in the pathological process. Despite the significant preva-lence of psoriasis and a large number of studies on this problem, there is still no single view on the pathogenesis of this dermatosis. To objectively understand the pathogenesis of psoriasis, it is necessary to take into account the insufficiently studied comorbidity of this pathology. Recently, an indisputable link between psoriasis and obesity has been proven. The scientific literature widely covers the issue of identical pathogenetic mechanisms of inflammatory processes in psoriasis and obesity. Given the current data on the role of systemic inflammation underlying the development of both psoriasis and obesity, the study of molecular mechanisms of its development and taking into account the role of proinflammatory nuclear transcription factors, thiazolidinediones are the pathogenetically justified drugs of choice for treatment of these diseases. In this study, we determined the effectiveness of using 15 mg of pioglitazone once a day for 6 months in the treatment of patients with extensive psoriasis vulgaris of moderate severity and concomitant grade І-ІІ alimentary obesity by clinical and immunological examination of systemic inflammation. Analyzing the results of the study, it was found that long-term use of pioglitazone, even in small doses, led to a decrease in systemic inflammation and con-tributed to a milder course of psoriasis in recurrence of the disease.Документ Features of the clinical course of psoriasis in patients with obesity(Українська медична стоматологічна академія, 2020) Yemchenko, Ya. О.; Ischeikin, K. Ye.; Ємченко, Яна Олександрівна; Іщейкін, Костянтин ЄвгеновичPsoriasis is the most common chronic, genetically determined autoimmune polyetiological inflammatory disease with im-paired epidermal proliferation, provoked by exogenous and endogenous factors, and manifested by erythematous and scaly elements, papules and plaques. According to the results of clinical and epidemiological studies, psoriasis affects about 3-4% of the population of our planet, regardless of gender, age, and ethnic group, and the specific gravity of this pathology in the general structure of skin diseases reaches, from the data of different authors, from 1% to 40 %. How-ever, despite the significant incidence of psoriasis and a large amount of research on this problem, there is still no single view of the pathogenesis of this dermatosis. For an objective understanding of the pathogenesis of psoriasis, it is neces-sary to take into account the insufficiently studied comorbidity of this pathology. Therefore, in the studies of the patho-genesis of psoriasis in recent years, more attention is paid to the impairment of metabolic processes. Recently, an indis-putable link between psoriasis and obesity has been proven. Obesity has been found to increase the risk of many dis-eases, including psoriasis. The literature has broadly highlighted the question of the pathogenetic mechanisms of in-flammatory processes in psoriasis and obesity that form a vicious circle at the level of the immune system, which must be broken for the successful treatment of these diseases. In this research, we studied the clinical presentation of the disease, measured anthropometric parameters, determined the grade of obesity by BMI, analyzed the history of life and disease, and conducted clinical and biochemical blood tests. The results of the study revealed that alimentary obesity in patients with psoriasis leads to metabolic disorders, complicating the course of dermatosis, which leads to a worsening of the DLQI of patients, the inefficiency of standard methods of therapy and frequent exacerbations of psoriatic disease. Therefore, the prospect for further research is a more in-depth study of the comorbidity of psoriatic disease, which will identify new targets for the treatment of this dermatosis to prevent complications and more effective treatment of this pathology.